Essex Woodlands Management as of Dec. 31, 2017
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 9 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revance Therapeutics | 24.8 | $137M | 3.8M | 35.75 | |
| Abiomed | 21.9 | $121M | 647k | 187.41 | |
| Axogen (AXGN) | 19.0 | $105M | 3.7M | 28.30 | |
| Corium Intl | 16.2 | $90M | 9.4M | 9.61 | |
| Entellus Medical Cm | 14.0 | $78M | 3.2M | 24.00 | |
| Endologix | 2.3 | $13M | 1.3M | 10.15 | |
| MediciNova (MNOV) | 1.4 | $7.6M | 1.2M | 6.47 | |
| Catalyst Biosciences | 0.2 | $1.1M | 79k | 13.88 | |
| Acura Pharmaceuticals (ACUR) | 0.1 | $783k | 2.0M | 0.40 |
